Acino : Geir Myklebust joins Group Management

NEWS RELEASE - PRESSEMITTEILUNG

Acino: Geir Myklebust joins Group Management Aesch, May 27, 2014, 07.00 hrs - Acino announced today the appointment of Geir Myklebust as Head of Projects and Process Improvement and a Member of Group Management.

Geir Myklebust joined the Acino Group from Takeda Pharmaceuticals International GmbH, where he was Head of Finance SSC (Shared Service Centers) Operations. Over his 20- year career he held several senior positions in finance and control with Nycomed. Geir Myklebust graduated from the Norwegian School of Management BI with a degree in Business Economics.

Håkan Björklund, Chairman of Acino Holding AG, commented: "Geir Myklebust is a very experienced finance manager. In addition, he has successfully managed integration and restructuring projects across different business units and functions. We are very pleased that Geir Myklebust has decided to join our company and will support our growth path."

About Acino

Acino (SIX: ACIN), a Swiss-based pharmaceutical company, develops, manufactures and internationally markets well-proven and innovative pharmaceuticals in novel drug delivery forms. Acino is a leader in advanced drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. As a partner of pharmaceutical companies worldwide, Acino supplies finished in-house developed products and/or provides customized one-stop solutions from product development and registration to contract manufacturing, packaging and logistics. Under the brand "Acino Switzerland", Acino markets Swiss-quality medicines in up and coming economies, currently 80 countries in the Middle East, Africa, Latin America and Asia. The Acino Group is headquartered in Aesch BL.
On December 12, 2013, Pharma Strategy Partners GmbH, a wholly-owned subsidiary of Avista Capital Partners and Nordic Capital, successfully completed its public tender offer for Acino Holding AG. Pharma Strategy Partners GmbH intends to effect a full takeover of Acino, and will delist the Acino shares from the stock exchange.

Contact

Robert Schmid
Media & Investor Relations Phone [phone] [e-mail]

Acino Holding AG

Dornacherstrasse 114

CH-4147 Aesch

Phone [phone]

Fax [phone] www.acino-pharma.com